Synthesis of 2′-C-methylcytidine and 2′-C-methyluridine derivatives modified in the 3′-position as potential antiviral agents

被引:13
|
作者
Pierra, Claire
Amador, Agnes
Badaroux, Eric
Storer, Richard
Gosselin, Gilles
机构
[1] Univ Montpellier 2, CNRS, Lab Cooperatif Idenix, F-34095 Montpellier 5, France
[2] Labs Idenix SARL, Lab Chim Med, Cap Gamma, F-34189 Montpellier, France
关键词
pyrimidines; antivirals; hepatitis C virus; 2 '-C-methyl branched ribonucleosides; deoxygenation; fluorination; RNA viruses; nucleosides;
D O I
10.1135/cccc20060991
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
As part of our anti-hepatitis C program, we recently discovered 2'-C-methylcytidine ( 1) and 2'-C-methyluridine ( 2), which are potent inhibitors in cell culture of several viruses ( bovine viral diarrhea virus ( BVDV), yellow fever virus (YFV)) closely related to HCV. In order to characterize structure - activity relationships, we introduced some structural and functional modifications into the 3'-position of 2'-C-methylcytidine and 2'-C-methyluridine. All these hitherto unknown compounds thus synthesized were tested for the activity against a wide range of viruses and found to be inactive.
引用
收藏
页码:991 / 1010
页数:20
相关论文
共 50 条
  • [21] SYNTHESIS OF POTENTIAL ANTIVIRAL AGENTS .2. PYRIDINE DERIVATIVES
    SADLER, PW
    JOURNAL OF ORGANIC CHEMISTRY, 1961, 26 (04): : 1315 - +
  • [22] Efficacy of 2'-C-Methylcytidine Against Yellow Fever Virus in a Hamster Model of Disease
    Julander, Justin
    Jha, Ashok
    Choi, Jung-Ae
    Smee, Don
    Morrey, John
    Chu, Chung
    ANTIVIRAL RESEARCH, 2010, 86 (01) : A35 - A36
  • [23] SYNTHESIS OF 3'-C-METHYLADENOSINE AND 3'-C-METHYLURIDINE DIPHOSPHATES AND THEIR INTERACTION WITH THE RIBONUCLEOSIDE DIPHOSPHATE REDUCTASE FROM CORYNEBACTERIUM-NEPHRIDII
    ONG, SB
    NELSON, LS
    HOGENKAMP, HPC
    BIOCHEMISTRY, 1992, 31 (45) : 11210 - 11215
  • [24] Synthesis of (4′R)-Azido-(2′R)-2′-Deoxy-2′-C-Methyluridine and Its Esters by Direct Iodide Displacement
    Benhaim, Cyril
    Lemaire, Sebastien
    Gaekens, Tim
    Govaerts, Tom
    Houpis, Iaonnis N.
    Reniers, Peter
    Van Looy, Anja
    Vermeulen, Wim A. A.
    Bernhardt, Sebastian
    Diene, Coura
    Knochel, Paul
    Farina, Vittorio
    SYNLETT, 2013, 24 (13) : 1697 - 1701
  • [25] Stabilization of Telomeric I-Motif Structures by (2′S)-2′-Deoxy-2′-C-Methylcytidine Residues
    Avino, Anna
    Dellafiore, Maria
    Gargallo, Raimundo
    Gonzalez, Carlos
    Iribarren, Adolfo M.
    Montserrat, Javier
    Eritja, Ramon
    CHEMBIOCHEM, 2017, 18 (12) : 1123 - 1128
  • [26] NM 283, an efficient prodrug of the potent anti-HCV agent 2′-C-methylcytidine
    Pierra, C
    Benzaria, S
    Amador, A
    Moussa, A
    Mathieu, S
    Storer, R
    Gosselin, G
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2005, 24 (5-7): : 767 - 770
  • [27] Nucleoside analogue 2'-C-methylcytidine inhibits hepatitis E virus replication but antagonizes ribavirin
    Qu, Changbo
    Xu, Lei
    Yin, Yuebang
    Peppelenbosch, Maikel P.
    Pan, Qiuwei
    Wang, Wenshi
    ARCHIVES OF VIROLOGY, 2017, 162 (10) : 2989 - 2996
  • [28] Ribavirin antagonizes the in vitro anti-hepatitis C virus activity of 2′-C-methylcytidine, the active component of valopicitabine
    Coelmont, Lotte
    Paeshuyse, Jan
    Windisch, Marc P.
    De Clercq, Erik
    Bartenschlager, Ralf
    Neyts, Johan
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (10) : 3444 - 3446
  • [29] 2′-C-methyluridine phosphoramidite:: a new building block for the preparation of RNA analogues carrying the 2′-hydroxyl group
    Gallo, M
    Monteagudo, E
    Cicero, DO
    Torres, HN
    Iribarren, AM
    TETRAHEDRON, 2001, 57 (27) : 5707 - 5713
  • [30] Synthesis and pharmacokinetics of valopicitabine (NM283), an efficient prodrug of the potent anti-HCV agent 2′-C-methylcytidine
    Pierra, Claire
    Amador, Agnes
    Benzaria, Samira
    Cretton-Scott, Erika
    D'Amours, Marc
    Mao, John
    Mathieu, Steven
    Moussa, Adel
    Bridges, Edward G.
    Standring, David N.
    Sommadossi, Jean-Pierre
    Storer, Richard
    Gosselin, Gilles
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (22) : 6614 - 6620